New cancer drug enters first human trials

NCT ID NCT06725381

Summary

This is the first study testing a new cancer drug called SKB571 in people. Researchers want to find the safest dose and see if it shows any early signs of fighting advanced solid tumors. The study will enroll about 138 adults whose cancer has spread or cannot be removed by surgery.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bei Jing Cancer Hospital

    NOT_YET_RECRUITING

    Beijing, China

    Contact

  • Chongqing University Cancer Hospital

    RECRUITING

    Chongqing, China

    Contact

  • Guangxi Medical University Cancer Hospital

    RECRUITING

    Nanning, Guangxi, China

    Contact

  • Guangxi Medical University Cancer Hospital

    RECRUITING

    Linyi, Shandong, China

    Contact

  • Hubei Cancer Hospital

    RECRUITING

    Wuhan, Hubei, China

    Contact

  • Hunan Cancer Hospital

    RECRUITING

    Changsha, Hunan, China

    Contact

  • Shandong Cancer Hospital

    RECRUITING

    Jinan, Shandong, China

    Contact

  • Shanghai East Hospital

    RECRUITING

    Shanghai, China

    Contact

  • Shanghai Pulmonary Hospital

    NOT_YET_RECRUITING

    Shanghai, China

    Contact

  • Si Chuan Cancer Hospital

    RECRUITING

    Chengdu, Sichuan, China

    Contact

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, China

    Contact

    Contact

  • The Affliated Hospital of Nanjing University Medical School

    RECRUITING

    Nanjing, Jiangsu, China

    Contact

  • West China Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, China

    Contact

    Contact

  • Zhejiang Cancer Hospital

    RECRUITING

    Hangzhou, Zhejiang, China

    Contact

  • Zhongshan Hospital

    RECRUITING

    Shanghai, China

    Contact

Conditions

Explore the condition pages connected to this study.